Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
1. A method of improving the resistance of a collagenous tissue having pyridinoline cross links to mechanical degradation comprising the steps of:
contacting at least a portion of a load bearing collagenous tissue within a human body with an effective amount of a crosslinking reagent having at least one crosslinking agent under conditions within physiologic limits to prevent tissue overheating whereby to improve the fatigue resistance of the tissue.
2. The method of claim 1 , wherein the at least one crosslinking agent is comprised of genipin.
3. The method of claim 1 , wherein the at least one crosslinking agent is comprised of proanthocyanidin.
4. The method of claim 1 , wherein the crosslinking reagent is comprised of a carrier medium and at least one crosslinking agent.
5. The method of claim 4 , wherein the crosslinking agent is selected from the group consisting of genipin and proanthrocyanidin and the carrier medium is a buffered saline solution.
6. The method of claim 4 , wherein the crosslinking agent is genipin, the carrier medium is a buffered saline solution, and a concentration of the genipin in the buffered saline solution is greater than 0.033%.
7. A method of improving the resistance of a collagenous tissue having pyridinoline cross links to mechanical degradation comprising the steps of:
contacting at least a portion of a load bearing collagenous tissue within a human body with an effective amount of a crosslinking reagent having at least one crosslinking agent under conditions within physiologic limits to prevent tissue overheating,
wherein the collagenous tissue is an intervertebral disc.
8. The method of claim 1 , wherein the collagenous tissue is articular cartilage.
9. The method of claim 1 , wherein the contact between the collagenous tissue and the crosslinking reagent is effected by injections directly into the portion of the collagenous tissue with a needle.
10. The method of claim 1 , wherein the contact between the collagenous tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the portion of the collagenous tissue.
11. The method of claim 10 , wherein the time-release delivery system is a gel or ointment.
12. The method of claim 10 , wherein the time-release delivery system is a treated membrane or patch.
13. The method of claim 10 , wherein the time-release delivery system is a treated patch.
14. The method of claim 1 , wherein the contact between the collagenous tissue and the crosslinking reagent is affected by soaking.
15. The method of claim 1 , further comprising the step of:
periodically re-contacting the portion of the collagenous tissue with an effective amount of a crosslinking reagent.
16. A method of improving the resistance of collagenous tissue having pyridinoline cross links to mechanical degradation comprising the steps of:
preparing a crosslinking reagent by dissolving a crosslinking agent in a carrier medium; and
contacting at least a portion of a load bearing collagenous tissue within a human body with an effective amount of the crosslinking reagent under conditions within physiologic limits to prevent tissue overheating whereby to improve the fatigue resistance of the tissue.
17. The method of claim 16 , wherein the contact between the collagenous tissue and the crosslinking reagent is affected by injections directly into the portion of the collagenous tissue with a needle.
18. The method of claim 16 , wherein the contact between the collagenous tissue and the crosslinking reagent is affected by placement of a time-release delivery system directly into or onto the portion of the collagenous tissue.
19. The method of claim 16 , wherein the contact between the collagenous tissue and the crosslinking reagent is affected by soaking.
20. The method of claim 16 , wherein the contact between the collagenous tissue and the crosslinking reagent is affected by spraying.
21. The method of claim 1 , further comprising the step of:
periodically re-contacting the portion of the collagenous tissue with an effective amount of the crosslinking reagent.
22. The method of claim 1 , further comprising the step of contacting collagenous tissue adjacent to the load bearing collagenous tissue.